Literature DB >> 17109239

Obstructive sleep apnea syndrome in Prader-Willi Syndrome: an unrecognized and untreated cause of cognitive and behavioral deficits?

Danny Camfferman1, Kurt Lushington, Fergal O'Donoghue, R Doug McEvoy.   

Abstract

Prader-Willi Syndrome (PWS) is a rare genetic disorder characterized by a range of physical, psychological, and physiological abnormalities. It is also distinguished by the high prevalence of obstructive sleep apnea syndrome (OSAS), i.e., repetitive upper airway collapse during sleep resulting in hypoxia and sleep fragmentation. In non-PWS populations, OSAS is associated with a range of neurocognitive and psychosocial deficits. Importantly, these deficits are at least partly reversible following treatment. Given the findings in non-PWS populations, it is possible that OSAS may contribute to neurocognitive and psychosocial deficits in PWS. The present review examines this possibility. While acknowledging a primary contribution from the primary genetic abnormality to central neural dysfunction in PWS, we conclude that OSAS may be an important secondary contributing factor to reduced neurocognitive and psychosocial performance. Treatment of OSAS may have potential benefits in improving neurocognitive performance and behavior in PWS, but this awaits confirmatory investigation.

Entities:  

Mesh:

Year:  2006        PMID: 17109239     DOI: 10.1007/s11065-006-9010-x

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  71 in total

Review 1.  Evaluation of excessive daytime sleepiness.

Authors:  M A Carskadon
Journal:  Neurophysiol Clin       Date:  1993-01       Impact factor: 3.734

2.  Sleep-disordered breathing and neuropsychological deficits. A population-based study.

Authors:  H C Kim; T Young; C G Matthews; S M Weber; A R Woodward; M Palta
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

3.  Respiratory control in children with Prader-Willi syndrome.

Authors:  B Schlüter; D Buschatz; E Trowitzsch; F Aksu; W Andler
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

4.  Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors.

Authors:  R Manni; L Politini; L Nobili; F Ferrillo; C Livieri; E Veneselli; R Biancheri; M Martinetti; A Tartara
Journal:  Clin Neurophysiol       Date:  2001-05       Impact factor: 3.708

5.  [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].

Authors:  S Nevsímalová; J Vanková; K Sonka; J Faraco; W Rogers; S Overeem; E Mignot
Journal:  Sb Lek       Date:  2000

Review 6.  What is the evidence that obstructive sleep apnoea is an important illness?

Authors:  O Marrone; M R Bonsignore; G Insalaco; G Bonsignore
Journal:  Monaldi Arch Chest Dis       Date:  1998-12

7.  Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome.

Authors:  K Cheshire; H Engleman; I Deary; C Shapiro; N J Douglas
Journal:  Arch Intern Med       Date:  1992-03

Review 8.  Sleep-disordered breathing and obesity.

Authors:  R R Grunstein; I Wilcox
Journal:  Baillieres Clin Endocrinol Metab       Date:  1994-07

9.  Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children.

Authors:  J L Carroll; S A McColley; C L Marcus; S Curtis; G M Loughlin
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

10.  Prader-Willi Syndrome after age 15 years.

Authors:  B M Laurance; A Brito; J Wilkinson
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

View more
  7 in total

1.  Drug-induced sleep endoscopy in children with Prader-Willi syndrome.

Authors:  Ming-Chin Lan; Yen-Bin Hsu; Ming-Ying Lan; Tsan-Jen Chiu; Tung-Tsun Huang; Shi-Bing Wong; Yu-Cheng Chen; Li-Ping Tsai
Journal:  Sleep Breath       Date:  2016-04-08       Impact factor: 2.816

2.  Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.

Authors:  Elisabeth M Dykens; Elizabeth Roof; Hailee Hunt-Hawkins
Journal:  J Child Psychol Psychiatry       Date:  2016-08-02       Impact factor: 8.982

Review 3.  Diagnosis and management of sleep disorders in Prader-Willi syndrome.

Authors:  Jessica Duis; Lara C Pullen; Maria Picone; Norman Friedman; Stephen Hawkins; Elise Sannar; Anna C Pfalzer; Althea Robinson Shelton; Deepan Singh; Phyllis C Zee; Daniel G Glaze; Amee Revana
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

4.  Improvement in quality of life after adenotonsillectomy in a child with Prader Willi syndrome.

Authors:  Chin-pang Wong; Daniel K Ng; Tracy M Ma; Christy Chau; Pok-yu Chow; Ka-li Kwok
Journal:  Sleep Breath       Date:  2009-09-09       Impact factor: 2.816

Review 5.  Molecular regulation of hypothalamic development and physiological functions.

Authors:  Yanxia Gao; Tao Sun
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

6.  Integrated transcriptomic response to cardiac chronic hypoxia: translation regulators and response to stress in cell survival.

Authors:  Dumitru A Iacobas; Chenhao Fan; Sanda Iacobas; Gabriel G Haddad
Journal:  Funct Integr Genomics       Date:  2008-05-01       Impact factor: 3.410

7.  Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population.

Authors:  Karim Sedky; David S Bennett; Andres Pumariega
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.